We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Royal Gold
RGLD
$17.2B
| $616K | 0.01% |
9,820
-374,259
| -97% | -$24.5M |
|
627
Marvell Technology
MRVL
$165B
| $614K | 0.01% |
+42,319
| New | +$575K |
|
|
BTU
628
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $613K | 0.01% |
5,276
+3,449
| +189% | +$514K |
|
629
CACI
CACI
$10.5B
| $612K | 0.01% |
+7,096
| New | +$578K |
|
630
CSX Corp
CSX
$93B
| $609K | 0.01% |
50,373
-576,807
| -92% | -$6.75M |
|
631
Jefferies Financial Group
JEF
$12.7B
| $608K | 0.01% |
30,270
+9,059
| +43% | +$187K |
|
632
Arthur J. Gallagher & Co
AJG
$65.9B
| $606K | 0.01% |
+12,860
| New | +$603K |
|
633
Nucor
NUE
$58.5B
| $604K | 0.01% |
+12,310
| New | +$641K |
|
634
Assurant
AIZ
$14B
| $603K | 0.01% |
+8,808
| New | +$586K |
|
635
Corning
GLW
$116B
| $603K | 0.01% |
26,263
-23,933
| -48% | -$487K |
|
|
ACHN
636
DELISTED
Achillion Pharmaceuticals
ACHN
| $603K | 0.01% |
+49,194
| New | +$601K |
|
637
Steven Madden
SHOO
$3.5B
| $599K | 0.01% |
28,194
+3,151
| +13% | +$67.2K |
|
|
GAP
638
The Gap Inc
GAP
$7.34B
| $599K | 0.01% |
14,220
-8,197
| -37% | -$321K |
|
|
BRP
639
DELISTED
BROOKFIELD RESIDENTIAL PROPERTIES INC
BRP
| $595K | 0.01% |
+24,660
| New | +$548K |
|
|
ALTR
640
DELISTED
Altera Corp
ALTR
| $593K | 0.01% |
+16,038
| New | +$567K |
|
|
CAVM
641
DELISTED
Cavium, Inc.
CAVM
| $591K | 0.01% |
9,553
-64,215
| -87% | -$3.4M |
|
642
Gilead Sciences
GILD
$163B
| $590K | 0.01% |
6,250
-4,116
| -40% | -$426K |
|
643
MGM Resorts International
MGM
$11.7B
| $590K | 0.01% |
27,583
+3,004
| +12% | +$65.3K |
|
|
ARRS
644
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $588K | 0.01% |
19,450
-1,872
| -9% | -$53K |
|
645
American Financial Group
AFG
$11.8B
| $586K | 0.01% |
+9,635
| New | +$573K |
|
|
AGU
646
DELISTED
Agrium
AGU
| $584K | 0.01% |
+6,159
| New | +$577K |
|
|
CHMT
647
DELISTED
Chemtura Corporation
CHMT
| $584K | 0.01% |
23,585
-171,000
| -88% | -$3.97M |
|
|
JNPR
648
DELISTED
Juniper Networks
JNPR
| $583K | 0.01% |
26,082
-76,813
| -75% | -$1.63M |
|
649
Kimberly-Clark
KMB
$36.6B
| $583K | 0.01% |
5,045
-2,539
| -33% | -$282K |
|
650
Leggett & Platt
LEG
$1.37B
| $581K | 0.01% |
13,631
+6,297
| +86% | +$248K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.